ACCORDI, BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.054
EU - Europa 403
AS - Asia 285
OC - Oceania 4
AF - Africa 1
SA - Sud America 1
Totale 3.748
Nazione #
US - Stati Uniti d'America 3.031
CN - Cina 176
DE - Germania 122
SG - Singapore 83
IT - Italia 73
FI - Finlandia 53
GB - Regno Unito 35
SE - Svezia 35
RU - Federazione Russa 24
CA - Canada 23
FR - Francia 23
UA - Ucraina 20
IN - India 14
VN - Vietnam 12
IE - Irlanda 8
NL - Olanda 7
AU - Australia 3
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
DK - Danimarca 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 3.748
Città #
Fairfield 537
Woodbridge 352
Chandler 326
Ann Arbor 251
Cambridge 233
Ashburn 213
Houston 185
Seattle 179
Wilmington 162
Singapore 66
Jacksonville 58
San Diego 57
Princeton 45
Beijing 42
Medford 36
Helsinki 34
Des Moines 28
Padova 28
Nanjing 22
Boardman 21
Shenyang 14
Dong Ket 12
North York 12
New York 11
Jinan 10
Santa Clara 10
Guangzhou 9
Dublin 8
Jiaxing 8
Ottawa 8
Chicago 7
Dearborn 7
Zhengzhou 7
Falls Church 6
Hebei 6
London 6
Los Angeles 6
Shanghai 6
Norwalk 5
Hefei 4
Kunming 4
Ogden 4
Amsterdam 3
Changsha 3
Fuzhou 3
Gunzenhausen 3
Hangzhou 3
Indiana 3
Kharkiv 3
Milan 3
Nanchang 3
Rovigo 3
Tianjin 3
Wandsworth 3
Bolgare 2
Borås 2
Dallas 2
Eboli 2
Hounslow 2
Lanzhou 2
Minneapolis 2
Portland 2
Pune 2
Rockville 2
Salerno 2
San Francisco 2
Selvazzano Dentro 2
Sydney 2
Taiyuan 2
Taizhou 2
Tappahannock 2
Baotou 1
Bengaluru 1
Bristol 1
Buccinasco 1
Chiswick 1
Citta Sant'angelo 1
Cividale del Friuli 1
Copenhagen 1
Cormeilles-en-Parisis 1
Dalmine 1
Delhi 1
Grafing 1
Hamilton 1
Jinhua 1
Johannesburg 1
Kilburn 1
Miami 1
Montréal 1
New Bedfont 1
Ningbo 1
Nuremberg 1
Nürnberg 1
Orange 1
Qingdao 1
Quzhou 1
Ravenna 1
Rosà 1
Roxbury 1
Sant'elena 1
Totale 3.144
Nome #
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia 167
Hovering between death and life: Natural apoptosis and phagocytes in the blastogenetic cycle of the colonial ascidian Botryllus schlosseri 141
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins 140
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints 139
Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL 138
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML. 134
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 133
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 124
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells 122
Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia 121
Expression and role of hERG1 channels in pediatric acute lymphoblastic Leukemias: Shortcoming of drug resistance by hERG1 channel inhibitors in stoma-supported leukaemia cell cultures in vitro. 120
Interleukin-22 in the diagnosis of active chronic graft-versus-host disease in paediatric patients 119
Ribociclib, a Cdk4/Cdk6 kinase inhibitor, enhances glucocorticoid sensitivity in B-acute lymphoblastic leukemia (B-All) 114
Targeting BAG-1: A novel strategy to increase drug efficacy in acute myeloid leukemia 113
Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells 112
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 111
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 109
Pre-clinical evaluation of second generation pim inhibitors for the treatment of t-cell acute lymphoblastic leukemia and lymphoma 108
Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction 100
Annexin 2A sustains glioblastoma cell dissemination and proliferation 100
Reverse Phase Protein Array (RPPA) of High Risk ALL 97
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 94
AMPK INHIBITION INDUCES APOPTOSIS IN PEDIATRIC B-ALL CELLS WITH MLL GENE REARRANGEMENTS 91
A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction. 91
The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. 89
SYK targeting represents a potential therapeutic option for relapsed resistant pediatric ETV6-RUNX1 B-acute lymphoblastic leukemia patients 88
Overcoming Chemotherapy Resistance in Childhood Acute Lymphoblastic Leukemia by Targeting Ion Channels. 83
miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma 82
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups. 81
JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction 76
USP7 cooperates with NOTch1 to drive the oncogenic transcriptional program in T-cell leukemia 72
Validation by RQ-PCR and flow cytometry of alpha-defensin 1-3 (DEFA 1-3) overexpression in relapsed and refractory acute lymphoblastic leucemia. 71
BAG1 Overexpression Restrains the Anti-Apoptotic BCL2, MCL1 and HSP70 Proteins in Acute Myeloid Leukemia 64
Phosphoproteomic profiling of pediatric B-ALL identifies in mill patients a new signaling pathway for targeted therapy 62
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia 52
Ruxolitinib as a novel therapeutic option for poor prognosis t-lbl pediatric patients 50
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups 32
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit 25
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis 21
NUP214-ABL1 fusion in childhood T-ALL 17
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells 13
Totale 3.816
Categoria #
all - tutte 14.232
article - articoli 14.232
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.464


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020712 0 0 9 36 76 65 95 100 117 106 66 42
2020/2021660 66 77 30 56 41 18 38 53 68 78 69 66
2021/2022657 30 58 73 34 30 36 113 46 28 15 75 119
2022/2023573 94 79 17 87 70 70 0 39 68 7 34 8
2023/2024266 11 50 30 22 22 30 16 10 7 16 25 27
2024/2025109 1 75 33 0 0 0 0 0 0 0 0 0
Totale 3.816